Source: earnings_events
Changes History →Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
Investment research built around change detection.
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
What changed: 3M Company (MMM) reported EPS of $2.40 vs. consensus estimate of $2.27, beating consensus by 5.7% for Q2 FY2026.
Source: earnings_events
Changes History →Monitor MMM's full Q2 FY2026 results for revenue growth, margin trends, and management guidance on second-half 2026 performance.
What changed: Ally Financial Inc. (ALLY) reported EPS of $1.21 vs. consensus estimate of $1.25, missing consensus by 3.2%.
Source: earnings_events
Changes History →Monitor the company's next earnings release and any guidance updates for signals of stabilization or further deterioration in earnings.
What changed: Valmont Industries, Inc. (VMI) reported Q2 FY2026 EPS of $6.14 vs. $5.76 consensus estimate, beating by 6.6% on 2026-07-21.
Source: earnings_events
Changes History →Monitor VMI's forward guidance and any analyst estimate revisions following the earnings beat to assess whether consensus expectations will be raised.
What changed: D.R. Horton, Inc. (DHI) reported EPS of $3.20 vs. $2.99 consensus estimate, beating by 7.0% on 2026-07-21.
Source: earnings_events
Changes History →Monitor DHI's next quarterly earnings report and any updates on home order trends or mortgage rate movements that could influence near-term demand.
What changed: Hasbro surged 9.50% to $89.34 after beating Q2 2026 earnings and raising full-year guidance, driven by a 27% revenue surge in Wizards of the Coast and Digital Gaming. Magic: The Gathering exceeded $500 million in quarterly revenue for the first time, topping analyst expectations, per Yahoo Finance.
Detected Jul 21, 3:30 PM ET
Changes History →Monitor full Q2 2026 earnings release details (balance sheet, cash flow, segment margins) and any updated guidance ranges; watch for analyst estimate revisions in the coming days.
What changed: Coinbase rallied 6.94% to $171.57, reversing recent weakness as crypto market sentiment shifted. A Motley Fool report (July 21) citing a top investment firm's view that the crypto market is nearing a bottom appears to have driven the intraday move, countering concerns from July 20 prediction-market chatter that COIN's Q2 trading volume would miss analyst estimates below $160 billion.
Detected Jul 21, 3:30 PM ET
Changes History →Coinbase's Q2 earnings release and actual trading volume disclosure; monitor whether the predicted sub-$160B volume materializes and how management guides Q3 volumes amid the broader market recovery narrative.
Danaher reported Q2 earnings that beat profit expectations but fell short on revenue guidance, trimming its core revenue growth outlook to 4% (down from 6%) and posting bioprocessing revenue of $1.92B versus the $1.97B consensus estimate (Reuters, Investors.com). The miss in its biotech unit—attributed to customer project timing despite strong order trends—overshadowed the profit forecast raise, sending DHR down 12.35% intraday from $201.11 to $176.27. The selloff was earnings-driven; the S&P 500 and Nasdaq both gained on the day, isolating the move to company-specific disappointment.
Danaher reported Q2 earnings that beat on profit but fell sharply—down 16.77% intraday to $167.38—after trimming full-year core revenue growth guidance to 2.0%–3.0% and missing on bioprocessing revenue due to customer project timing delays (Reuters, July 21). Despite raising its annual profit forecast, the revenue miss and weakened outlook overshadowed the bottom-line beat; one analyst called bioprocessing sales 'surprisingly soft.' The broader market (S&P 500, Nasdaq) gained on the day, isolating the decline to company-specific factors.
Related research: Why did Danaher (DHR) stock fall ~13% on July 21, 2026 — a beat-and-raise undone by a core revenue guidance cut →
Monitor Danaher's upcoming quarterly conference call for color on bioprocessing project timing, customer demand sustainability, and any revised 2026 revenue guidance; also track biotech peer earnings (Avantor, Sartorius) for sector-wide project-delay signals.
What changed: TD Cowen raised its price target on UCTT to $130, citing strengthening AI infrastructure demand and confidence in the company's new CFO appointment (Michael Keogh), according to the web catalyst. The stock gained 8.20% to $99.28, though volume remains below average at 0.59x the historical norm for this point in the session. The move was reinforced by sector-wide strength in semiconductors and tech following a softer-than-expected June CPI print.
Detected Jul 21, 3:30 PM ET
Changes History →August earnings report and management commentary on AI infrastructure order trends; watch for confirmation of the price target upgrade by other analysts and whether volume accelerates into the close.
What changed: DigitalOcean (DOCN) rose 10.50% to $131.59 in early trading as the Information Technology sector rallied on renewed market optimism following a U.S.–Iran ceasefire and accelerated AI investment flows, per Yahoo Finance. The move occurred 32 minutes into the session with volume data still unreliable at this early stage.
Detected Jul 21, 3:30 PM ET
Changes History →DigitalOcean's Q2 2026 earnings conference call; final close volume and sector momentum through market close.
Coherent shares surged 11.59% to $318.47, though no specific intraday catalyst emerged in available sources. The company is tracked within business services comparisons (per Zacks), and volume of 2.5M shares ran at 0.92x expected pace — normal for this point in the session — offering no signal of unusual accumulation or sector-wide movement.
Coherent rose 7.18% to $305.90 in intraday trading, though no specific news catalyst was identified in available sources. The move occurs against a backdrop of technical indicators showing a Strong Sell signal based on moving averages (MA5–MA200) as of 2026-07-20, suggesting the rally may be contrarian to the prevailing technical setup.
Watch for official company news or earnings announcements; if none materializes, track whether the move holds into close or reverses, and monitor peer performance in business services to assess sector participation.
Western Digital surged 11.86% to $545.25 after beating fiscal third-quarter earnings and revenue expectations, driven by robust cloud and enterprise storage demand and an improved pricing environment that lifted margins above guidance, according to 247wallst.com. The rally was amplified by sector-wide optimism in memory and storage stocks—SanDisk +8%, Micron +7%—as easing geopolitical tensions and tech gains lifted the Information Technology sector.
Western Digital jumped 8.49% to $528.81 after beating fiscal Q3 earnings expectations with revenue and profit above forecasts, driven by robust cloud and enterprise storage demand and improved pricing that lifted margins above guidance (web catalyst synthesis). The rally was amplified by sector-wide semiconductor strength as investors rotated back into memory stocks on renewed confidence in AI-driven demand and easing geopolitical tensions.
Monitor WDC's forward guidance for cloud and enterprise segment trends, and track whether the improved memory pricing environment persists into fiscal Q4 2026.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.

Why did Danaher (DHR) stock fall ~13% on July 21, 2026 — a beat-and-raise undone by a core revenue guidance cut
Danaher fell nearly 13% on July 21, 2026 despite beating on adjusted EPS and raising its full-year earnings guidance. The company tied that raise partly to completing the Masimo acquisition early — while cutting full-year core revenue growth guidance to 3–4% from 3–6% and marking bioprocessing down to mid-single-digit growth. The market paid for the organic line, not the inorganic one. Bioprocessing peers Repligen and Sartorius fell in sympathy while instrument makers rose, on a day the broad market was up ~1%.
Why did Hut 8 (HUT) stock jump ~11% on July 20, 2026 — a second $9.8 billion Beacon Point lease that fully commercializes a 1 GW campus
Hut 8 jumped about 11% on July 20, 2026 after a second 352 MW, 15-year, $9.8 billion lease fully commercialized its 1 GW Beacon Point campus in Texas — signed by the same unnamed tenant that took Phase 1 in May. The deeper significance is financing: Phase 1 was funded with $4.25 billion of non-recourse, Baa2-rated notes, and an anchor lease is the precondition for repeating that. But the move only round-trips a two-session drop, leaving the stock below where it closed on Wednesday.

Why did Alcoa (AA) stock fall ~6% on July 17, 2026 — a record Q2 that still missed, and an alumina guidance cut
Alcoa closed down 6.1% on July 17, 2026 — far more than its aluminum peers or the metal itself. Its Q2 set a revenue record and grew adjusted EPS more than fivefold, but it missed an elevated Street bar and cut full-year alumina guidance after cyclone-related outages at its Pinjarra refinery. The drop confirmed an aluminum-surplus bear case analysts had already been pricing in, and it layers dilution and integration questions from the pending South32 acquisition on top.

Why did Cadence Design Systems (CDNS) stock fall ~10% on July 17, 2026 — Kimi K3 and the EDA selloff?
Cadence fell about 10% intraday on July 17, 2026 — far more than the broad chip group, which pared its morning losses. Market coverage tied the EDA pair's underperformance to Moonshot's Kimi K3, which the company says designed a 45nm chip in simulation using only open-source tools. It's an early, reported proof of concept, set against a broad semiconductor retreat — and it overwhelmed Cadence's own Rapidus AI partnership and Benchmark's $450 Buy call.

Why did Intuitive Surgical (ISRG) stock plunge ~13% on July 17, 2026 — despite a Q2 earnings beat?
Intuitive Surgical dropped about 13% intraday to a fresh 52-week low the morning after beating Q2 estimates. The catalyst was the outlook, not the quarter: full-year da Vinci procedure-growth guidance of 13.5–15.5% implies a second-half deceleration, with moderating U.S. demand and an ACA coverage headwind. A ~40x multiple left no room for it, and six firms cut targets within hours — while the rest of medtech barely moved.

Why did Bloom Energy (BE) stock plunge ~14% on July 16, 2026 — despite a $1.7B AI-power deal?
Bloom Energy dropped about 14% intraday on the same day IDF and Oaktree announced a $1.7 billion project financing to power Nebius's AI build-out. The move reads as 'sell the news' — profit-taking on a stock priced north of 250x EV/EBITDA, a fuel-cell-complex derating (FCEL −16%), and a broad AI-capex risk-off — with a thinly-detailed deal and the prior week's short-seller overhang in the background.











